Sareum (SAR) AGM 2025 summary

Opening remarks and agenda

• Meeting opened with formal business, followed by a research update and Q&A session, with questions from both in-person attendees and the IMC platform addressed as time allowed.

• Board members and their roles were introduced, and the AGM notice was confirmed as properly distributed.

Financial performance review

• Fixed annual costs estimated at approximately GBP 900,000, excluding potential new executive hires.

• Company eligible for EIS funding, supporting investment incentives.

• Remuneration Committee benchmarks salaries and bonuses against AIM peers, with executive pay at or below median and bonuses only for exceptional performance.

Board and executive committee updates

• Board prioritizes hiring a Chief Medical Officer over a CEO, with consultancy options considered to manage costs and expertise needs.

• Contingency plans in place for key personnel risks, including insurance and consultant support.